Johnson & Johnson has proposed a $5.5 billion talc settlement in an effort to bring its long-running legal battle over talc products closer to an end. The company said the agreement would address the remaining lawsuits alleging that its talc products caused ovarian cancer.
The proposed deal marks a major step in a case that has weighed on the drugmaker for years. Johnson & Johnson has faced sustained litigation over talc-related claims, and this latest move is aimed at resolving the outstanding cases in one broad settlement.
According to the company, the plan is not yet final and is subject to conditions. That means the $5.5 billion talc settlement proposal still depends on further steps before it can fully close out the remaining lawsuits.
The announcement underscores the scale of the talc litigation for Johnson & Johnson and the company's effort to end a costly and lengthy court fight. If completed, the settlement would represent one of the most significant attempts yet to wrap up the ovarian cancer claims tied to its talc products.
